logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > China Stock

Beijing Zhidemai Technology (300785.SZ) shareholder and director Liu Chao collectively reduced holdings by 1.6014 million shares.

date
20:29 21/01/2025
avatar
GMT Eight
(300785.SZ) announcement, the company's shareholder and director Liu Chao will be on leave from April 15, 2023 to...
Beijing Zhidemai Technology (300785.SZ) announced that shareholder and director Liu Chao has reduced his holdings of the company's shares by a total of 1.6014 million shares from April 15, 2023 to January 17, 2025.
Related Articles
HK Stock
Metasurface (08637) will be suspended from trading starting on January 14th, waiting for the release of insider information.
New Stock Outlook | Xizi Health: Annual income exceeds 1.6 billion yuan vs 99% of income relies on online sales. Is "Success comes from Douyin, worries also from Douyin"?
HK Stock Market Move | XTALPI (02228) rises by over 4% again, ReviR's innovative drug RTX-117 obtains clinical approval in China and the United States.
Metasurface (08637) will be suspended from trading starting on January 14th, waiting for the release of insider information.
HK Stock
New Stock Outlook | Xizi Health: Annual income exceeds 1.6 billion yuan vs 99% of income relies on online sales. Is "Success comes from Douyin, worries also from Douyin"?
HK Stock Market Move | XTALPI (02228) rises by over 4% again, ReviR's innovative drug RTX-117 obtains clinical approval in China and the United States.
RECOMMEND
Institutions Bullish On Hong Kong Stocks As Spring Rally Builds; Domestic And Foreign Capital Increase ETF Allocations
Institutions Bullish On Hong Kong Stocks As Spring Rally Builds; Domestic And Foreign Capital Increase ETF Allocations
icon
13/01/2026
The Sword Over Hong Kong Stocks: IPO Peaks And Unlocking Waves
The Sword Over Hong Kong Stocks: IPO Peaks And Unlocking Waves
icon
13/01/2026
Learning From History: The AI Investment Wave Likely To End This Year, But The Fed May Shield U.S. Stocks
Learning From History: The AI Investment Wave Likely To End This Year, But The Fed May Shield U.S. Stocks
icon
13/01/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.